P. Richardson

Intravenous zoledronic acid in postmenopausal women with low bone mineral density.

Jacques P. Brown, D. Felsenberg, J. Kaufman, 2002, The New England journal of medicine.

Comparison of a single infusion of zoledronic acid with risedronate for Paget's disease.

Jacques P. Brown, I. Reid, P. Miller, 2005, The New England journal of medicine.

Biochemical deficiencies of coenzyme Q10 in HIV-infection and exploratory treatment.

K. Folkers, Y. Nara, J. Komorowski, 1988, Biochemical and biophysical research communications.

Evaluation of adverse experiences related to pamidronate infusion in Paget’s disease of bone

D. Anderson, S. Hollis, C. E. Davison, 1998, Annals of the rheumatic diseases.

Home 5-HTP ArginMax Bacopa Blueberry Bromelain Curcumin DMAE Fish Oil Green Tea Guggul About Us Gymnema Huperzine Lipoic Acid Nattokinase Pantethine Policosanol Red Yeast Rice SAM-e St. John's Wort Theanine

N. Ma, J. Whitaker, P. Richardson, 2012 .

A double blind trial of gefarnate and placebo in the treatment of gastric ulcer.

P. Newcomb, A. Gent, W. Stone, 1976, The Practitioner.

Increase in levels of IgG in serum of patients treated with coenzyme Q10.

S. Shizukuishi, J. Drzewoski, K. Folkers, 1982, Research communications in chemical pathology and pharmacology.

Bioenergetics in clinical medicine. XVI. Reduction of hypertension in patients by therapy with coenzyme Q10.

S Shizukuishi, S. Shizukuishi, J. Drzewoski, 1981, Research communications in chemical pathology and pharmacology.

Intravenous zoledronic acid in postmenopausal women with low bone mineral density

Jacques P. Brown, J. Kaufman, I. Reid, 2003 .

A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. PROOF Study Group.

D. Kiel, S. Silverman, H. Genant, 2000, The American journal of medicine.